C07D 277/34
Oxygen atoms
C07D277/34 (Oxygen atoms) appears on 535 US grants and 384 published applications in this corpus.
Search patents in C07D- Granted patents
- 535
- Published applications
- 384
- Assignees
- 278
- Inventors
- 1,581
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 6 | 0 |
| 1978 | 5 | 0 |
| 1979 | 4 | 0 |
| 1980 | 5 | 0 |
| 1981 | 7 | 0 |
| 1982 | 6 | 0 |
| 1983 | 10 | 0 |
| 1984 | 9 | 0 |
| 1985 | 6 | 0 |
| 1986 | 6 | 0 |
| 1987 | 8 | 0 |
| 1988 | 11 | 0 |
| 1989 | 3 | 0 |
| 1990 | 13 | 0 |
| 1991 | 10 | 0 |
| 1992 | 14 | 0 |
| 1993 | 10 | 0 |
| 1994 | 10 | 0 |
| 1995 | 10 | 0 |
| 1996 | 18 | 0 |
| 1997 | 26 | 0 |
| 1998 | 6 | 0 |
| 1999 | 18 | 0 |
| 2000 | 14 | 0 |
| 2001 | 17 | 5 |
| 2002 | 17 | 20 |
| 2003 | 19 | 23 |
| 2004 | 19 | 17 |
| 2005 | 12 | 23 |
| 2006 | 9 | 25 |
| 2007 | 11 | 15 |
| 2008 | 11 | 11 |
| 2009 | 6 | 23 |
| 2010 | 18 | 18 |
| 2011 | 14 | 16 |
| 2012 | 9 | 9 |
| 2013 | 7 | 15 |
| 2014 | 10 | 20 |
| 2015 | 19 | 18 |
| 2016 | 15 | 16 |
| 2017 | 14 | 12 |
| 2018 | 8 | 17 |
| 2019 | 6 | 8 |
| 2020 | 10 | 20 |
| 2021 | 8 | 4 |
| 2022 | 11 | 16 |
| 2023 | 8 | 9 |
| 2024 | 7 | 11 |
| 2025 | 5 | 8 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- CGAS antagonist compounds16 Jun 2026US 12,655,118 B2Board of Regents, The University of Texas System
- Split photoactive yellow protein complementation system and uses thereof31 Mar 2026US 12,590,127 B2Centre National De La Recherche Scientifique
- Compound as PPAR agonist and application thereof10 Feb 2026US 12,545,653 B2USA Elixiria Biotech Inc.
- Stacked organic electroluminescent device28 Oct 2025US 12,454,538 B2Beijing Summer Sprout Technology Co., Ltd.
- Acylsulfonamide KAT6A inhibitors30 Sep 2025US 12,428,379 B2Aurigene Oncology Limited
- Cgas antagonist compounds17 Sep 2026US 2026/0274808 A1Board of Regents, The University of Texas System
- Therapy based on synthetic lethality in swi/snf complex-dysfunction cancer27 Aug 2026US 2026/0248806 A1National Cancer Center
- Modulators of mas-related g-protein receptor x4 and related products and methods23 Apr 2026US 2026/0108482 A1Escient Pharmaceuticals, Inc.
- Butenolide compounds containing thiazolidinone structure as well as preparation method therefor and use thereof23 Apr 2026US 2026/0109693 A1China Agricultural University
- Acylsulfonamide kat6a inhibitors15 Jan 2026US 2026/0015327 A1Aurigene Oncology Limited
Most cited
By later US patents
- Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof277US 5,549,974 AAffymax Technologies N.V. · 1996
- Photolabile compounds and methods for their use151US 5,739,386 AAffymax Technologies N.V. · 1998
- Thiazolylacetamido cephalosporin type compounds148US 4,098,888 ATakeda Chemical Industries, Ltd. · 1978
- Thermal inkjet printhead and high-efficiency polycrystalline silicon resistor system for use therein141US 6,315,384 B1Hewlett-Packard Company · 2001
- Retroviral protease inhibiting compounds94US 5,541,206 AAbbott Laboratories · 1996